
Patrick J. Nolan
Examiner (ID: 19485)
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1644, 1816, 1621 |
| Total Applications | 523 |
| Issued Applications | 285 |
| Pending Applications | 114 |
| Abandoned Applications | 124 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1114823
[patent_doc_number] => 06800290
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-10-05
[patent_title] => 'Variants of allergenic proteins of the group 2 of dermatophagoides'
[patent_app_type] => B2
[patent_app_number] => 09/949889
[patent_app_country] => US
[patent_app_date] => 2001-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2460
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/800/06800290.pdf
[firstpage_image] =>[orig_patent_app_number] => 09949889
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/949889 | Variants of allergenic proteins of the group 2 of dermatophagoides | Sep 11, 2001 | Issued |
Array
(
[id] => 5921137
[patent_doc_number] => 20020114806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Uses of mammalian genes and related reagents'
[patent_app_type] => new
[patent_app_number] => 09/949781
[patent_app_country] => US
[patent_app_date] => 2001-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7870
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20020114806.pdf
[firstpage_image] =>[orig_patent_app_number] => 09949781
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/949781 | Uses of mammalian genes and related reagents | Sep 9, 2001 | Abandoned |
Array
(
[id] => 6374877
[patent_doc_number] => 20020119152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-29
[patent_title] => 'Anti-TNFalpha antibodies in therapy of asthma'
[patent_app_type] => new
[patent_app_number] => 09/942075
[patent_app_country] => US
[patent_app_date] => 2001-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8948
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20020119152.pdf
[firstpage_image] =>[orig_patent_app_number] => 09942075
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/942075 | Anti-TNFalpha antibodies in therapy of asthma | Aug 27, 2001 | Abandoned |
Array
(
[id] => 5873855
[patent_doc_number] => 20020048775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => 'Diagnostic methods for asthma'
[patent_app_type] => new
[patent_app_number] => 09/931287
[patent_app_country] => US
[patent_app_date] => 2001-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8501
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20020048775.pdf
[firstpage_image] =>[orig_patent_app_number] => 09931287
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/931287 | Diagnostic methods for asthma | Aug 15, 2001 | Abandoned |
Array
(
[id] => 6378285
[patent_doc_number] => 20020119553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-29
[patent_title] => 'Human secreted protein, ZZP1'
[patent_app_type] => new
[patent_app_number] => 09/922488
[patent_app_country] => US
[patent_app_date] => 2001-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22972
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20020119553.pdf
[firstpage_image] =>[orig_patent_app_number] => 09922488
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/922488 | Human secreted protein, Zzp1 | Aug 2, 2001 | Issued |
Array
(
[id] => 6429431
[patent_doc_number] => 20020127235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Identification and molecular characterization of proteins, expressed in the Ixodes ricinus salivary glands'
[patent_app_type] => new
[patent_app_number] => 09/910430
[patent_app_country] => US
[patent_app_date] => 2001-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14828
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20020127235.pdf
[firstpage_image] =>[orig_patent_app_number] => 09910430
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/910430 | Identification and molecular characterization of proteins, expressed in the Ixodes ricinus salivary glands | Jul 18, 2001 | Issued |
| 09/904492 | Biologically active peptides | Jul 12, 2001 | Abandoned |
Array
(
[id] => 6032079
[patent_doc_number] => 20020018779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'Non-anaphylactic forms of allergens and their use'
[patent_app_type] => new
[patent_app_number] => 09/897042
[patent_app_country] => US
[patent_app_date] => 2001-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6341
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20020018779.pdf
[firstpage_image] =>[orig_patent_app_number] => 09897042
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/897042 | Non-anaphylactic forms of allergens and their use | Jul 2, 2001 | Issued |
Array
(
[id] => 6429201
[patent_doc_number] => 20020127217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Phosphatidylinositol 4,5-bisphosphate 5-phosphatase'
[patent_app_type] => new
[patent_app_number] => 09/892287
[patent_app_country] => US
[patent_app_date] => 2001-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 19150
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20020127217.pdf
[firstpage_image] =>[orig_patent_app_number] => 09892287
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/892287 | Phosphatidylinositol 4,5-bisphosphate 5-phosphatase | Jun 25, 2001 | Abandoned |
Array
(
[id] => 6082989
[patent_doc_number] => 20020082391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Human occludin, its uses and enhancement of drug absorption using occludin inhibitors'
[patent_app_type] => new
[patent_app_number] => 09/891064
[patent_app_country] => US
[patent_app_date] => 2001-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9819
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20020082391.pdf
[firstpage_image] =>[orig_patent_app_number] => 09891064
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/891064 | Human occludin, its uses and enhancement of drug absorption using occludin inhibitors | Jun 24, 2001 | Abandoned |
Array
(
[id] => 6755741
[patent_doc_number] => 20030003518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-02
[patent_title] => 'Nuclear envelope protein recognized by atypical p-ANCA in patients with inflammatory bowel disease and autoimmune liver diseases'
[patent_app_type] => new
[patent_app_number] => 09/882325
[patent_app_country] => US
[patent_app_date] => 2001-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11129
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20030003518.pdf
[firstpage_image] =>[orig_patent_app_number] => 09882325
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/882325 | Nuclear envelope protein recognized by atypical p-ANCA in patients with inflammatory bowel disease and autoimmune liver diseases | Jun 14, 2001 | Issued |
Array
(
[id] => 6683866
[patent_doc_number] => 20030119730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Human phospholipid binding proteins'
[patent_app_type] => new
[patent_app_number] => 09/879401
[patent_app_country] => US
[patent_app_date] => 2001-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 21549
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119730.pdf
[firstpage_image] =>[orig_patent_app_number] => 09879401
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/879401 | Human phospholipid binding proteins | Jun 10, 2001 | Abandoned |
Array
(
[id] => 6432730
[patent_doc_number] => 20020127621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'KUZ, a novel family of metalloproteases'
[patent_app_type] => new
[patent_app_number] => 09/871388
[patent_app_country] => US
[patent_app_date] => 2001-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11180
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20020127621.pdf
[firstpage_image] =>[orig_patent_app_number] => 09871388
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/871388 | KUZ, a novel family of metalloproteases | May 30, 2001 | Abandoned |
Array
(
[id] => 5800858
[patent_doc_number] => 20020009453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-24
[patent_title] => 'Polyclonal antibody composition for treating allergy'
[patent_app_type] => new
[patent_app_number] => 09/866573
[patent_app_country] => US
[patent_app_date] => 2001-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9507
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20020009453.pdf
[firstpage_image] =>[orig_patent_app_number] => 09866573
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/866573 | Polyclonal antibody composition for treating allergy | May 24, 2001 | Issued |
Array
(
[id] => 990902
[patent_doc_number] => 06919429
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-19
[patent_title] => 'Prostate associated Ets protein'
[patent_app_type] => utility
[patent_app_number] => 09/866356
[patent_app_country] => US
[patent_app_date] => 2001-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 21525
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/919/06919429.pdf
[firstpage_image] =>[orig_patent_app_number] => 09866356
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/866356 | Prostate associated Ets protein | May 23, 2001 | Issued |
Array
(
[id] => 5814678
[patent_doc_number] => 20020039734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-04
[patent_title] => 'Compositions, kits, and methods for identification and modulation of T helper-1 and T helper-2 cells and diseases associated therewith'
[patent_app_type] => new
[patent_app_number] => 09/860655
[patent_app_country] => US
[patent_app_date] => 2001-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 47240
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20020039734.pdf
[firstpage_image] =>[orig_patent_app_number] => 09860655
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/860655 | Compositions, kits, and methods for identification and modulation of T helper-1 and T helper-2 cells and diseases associated therewith | May 16, 2001 | Abandoned |
Array
(
[id] => 5829446
[patent_doc_number] => 20020068825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-06
[patent_title] => 'Novel human DBI/ACBP-like protein'
[patent_app_type] => new
[patent_app_number] => 09/859101
[patent_app_country] => US
[patent_app_date] => 2001-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16197
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20020068825.pdf
[firstpage_image] =>[orig_patent_app_number] => 09859101
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/859101 | Novel human DBI/ACBP-like protein | May 13, 2001 | Abandoned |
Array
(
[id] => 6405159
[patent_doc_number] => 20020037538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-28
[patent_title] => 'Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis'
[patent_app_type] => new
[patent_app_number] => 09/852400
[patent_app_country] => US
[patent_app_date] => 2001-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 52336
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20020037538.pdf
[firstpage_image] =>[orig_patent_app_number] => 09852400
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/852400 | Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis | May 8, 2001 | Abandoned |
Array
(
[id] => 5828364
[patent_doc_number] => 20020068303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-06
[patent_title] => 'Antigenic polypeptide sequences of factor VIII, and fragments and/or epitopes of these sequences'
[patent_app_type] => new
[patent_app_number] => 09/853080
[patent_app_country] => US
[patent_app_date] => 2001-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12836
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20020068303.pdf
[firstpage_image] =>[orig_patent_app_number] => 09853080
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/853080 | Antigenic polypeptide sequences of factor VIII, and fragments and/or epitopes of these sequences | May 8, 2001 | Abandoned |
Array
(
[id] => 1188531
[patent_doc_number] => 06733762
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-05-11
[patent_title] => 'Method of using Zot to inhibit lymphocyte proliferation in an antigen-specific manner'
[patent_app_type] => B1
[patent_app_number] => 09/786319
[patent_app_country] => US
[patent_app_date] => 2001-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 22
[patent_no_of_words] => 16956
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/733/06733762.pdf
[firstpage_image] =>[orig_patent_app_number] => 09786319
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/786319 | Method of using Zot to inhibit lymphocyte proliferation in an antigen-specific manner | May 2, 2001 | Issued |